Dutasteride

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1373 publications

Damp scalp application enhances follicular delivery of dutasteride loaded in liposomes compared to dry scalp.

Damp scalp application enhances follicular delivery of dutasteride loaded in liposomes compared to dry scalp.

Journal: Therapeutic delivery
Published: June 19, 2026

Baseline Gut Microbiome-Metabolome Signatures Are Associated with Drinking Severity and Reduction Following Dutasteride Treatment in Alcohol Use Disorder.

Baseline Gut Microbiome-Metabolome Signatures Are Associated with Drinking Severity and Reduction Following Dutasteride Treatment in Alcohol Use Disorder.

Journal: medRxiv : the preprint server for health sciences
Published: June 12, 2026

The effect of dutasteride on storage symptoms in men with lower urinary tract symptoms: a REDUCE trial analysis.

The effect of dutasteride on storage symptoms in men with lower urinary tract symptoms: a REDUCE trial analysis.

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: April 21, 2026

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management.

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management.

Journal: Medicina (Kaunas, Lithuania)
Published: April 09, 2026

Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS).

Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS).

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: March 24, 2026

Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series.

Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series.

Journal: Journal of drugs in dermatology : JDD
Published: March 04, 2026

Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement.

Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement.

Journal: Postgraduate medicine
Published: February 23, 2026

Dutasteride treatment and its effect on standardized uptake values in prostate-specific membrane antigen-PET imaging: A pilot study.

Dutasteride treatment and its effect on standardized uptake values in prostate-specific membrane antigen-PET imaging: A pilot study.

Journal: PloS one
Published: February 18, 2026

Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review.

Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review.

Journal: Dermatology and therapy
Published: February 16, 2026

Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study.

Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study.

Journal: Frontiers in pharmacology
Published: February 14, 2026

Successful Hair Regrowth in Early Frontal Fibrosing Alopecia With Combination Therapy.

Successful Hair Regrowth in Early Frontal Fibrosing Alopecia With Combination Therapy.

Journal: Cureus
Published: February 12, 2026

Multi-Target Inhibition of F10/F2/PAR1 Through In Silico Drug Repurposing of Avodart and Naldemedine to Prevent Thrombotic-Induced Sudden Cardiac Arrest.

Multi-Target Inhibition of F10/F2/PAR1 Through In Silico Drug Repurposing of Avodart and Naldemedine to Prevent Thrombotic-Induced Sudden Cardiac Arrest.

Journal: Biomedicines
Published: February 12, 2026
Showing 1-12 of 1,373

Last Updated: 06/30/2026